Hakan Uçar

Treatment guide

What Is a Super High-Pressure Coronary Balloon?

Treatment guide 12 min read
Medical illustration of a temporary super high-pressure non-compliant balloon inflated in a calcified coronary stenosis

Super high-pressure non-compliant coronary balloon is a temporary balloon catheter used in some rigid or calcified coronary stenoses that cannot be expanded adequately with a standard non-compliant (NC) balloon. It may help prepare the artery for a stent or, in selected cases, expand an under-expanded stent. It is not required for every calcified stenosis and has not been shown to be superior to other methods for every patient.[35]

What does a super high-pressure coronary balloon mean?

Dense calcium can stiffen the vessel wall and stenosis so that a standard balloon or stent cannot expand fully. Super high-pressure non-compliant balloons are designed to apply expansion force while keeping diameter more controlled in selected resistant lesions.[35]

OPN NC, often seen in the literature, is a specific device/platform name—not the generic method name. Its double-layer or “balloon-in-balloon” design aims for different pressure tolerance than a standard NC balloon.[5,22] That design does not mean the device scrapes, drills or clears all calcium from the artery.

The balloon is temporary and removed with the catheter. If a stent is placed, the lasting structure is the stent, not the balloon.[20,21]

How does it differ from a standard NC balloon?

Both standard NC and super high-pressure balloons are designed so diameter changes only modestly as pressure rises. The key difference is that the super high-pressure device is developed for selected resistant lesions. This does not mean a standard NC balloon is inadequate or unnecessary; many lesions respond well to a standard NC balloon.[3,4]

FeatureStandard NC balloonSuper high-pressure non-compliant balloon
Main use contextLesion preparation and controlled post-stent expansionSelected resistant lesions not adequately opened by a standard NC balloon
StructureSingle-layer products are commonCertain platforms are described as double-layer designs
Needed in every patient?No; chosen by lesionNo; a specialised, selected tool
Removes calcium?NoNo
Remains in the artery?NoNo
Main evidence focusBroad PCI experienceProcedural and imaging endpoints; comparative long-term clinical evidence is more limited
Structural comparison of a standard non-compliant balloon and a double-layer super high-pressure coronary balloon
A super high-pressure balloon is not a routine replacement for every NC balloon; it is a different tool for selected resistant lesions.

When may it be considered?

When the balloon crosses but the stenosis does not open

The clearest use case is a lesion that a balloon can cross but a standard NC balloon cannot expand adequately (“balloon-crossable but balloon-undilatable”). Failure to cross at all is a different problem and may need other devices first.[35,8,9]

In heavily calcified de novo lesions

ISAR-CALC compared a super high-pressure balloon with a scoring balloon after inadequate NC-balloon preparation in severe calcium (74 patients). OCT stent-expansion index was similar. Some secondary angiographic measures favoured the super high-pressure balloon, but the trial was not sized to show fewer deaths, infarctions or repeat procedures.[5]

In under-expanded stents or in-stent restenosis

Calcium-related stent underexpansion matters for restenosis and thrombosis risk. Super high-pressure balloons have been reported in selected underexpansion or ISR cases.[12,13,23] Applying higher pressure alone without identifying the mechanism is not appropriate.

When it may not be enough alone

  • Lesions that balloons or imaging catheters cannot cross
  • Long, diffuse or superficial calcium needing another modification method
  • Heavy stent underexpansion where calcium lies outside the stent
  • Vessel size, tortuosity or location making balloon use unsuitable
  • Dissection or flow-limiting vessel injury during the procedure

Rotational atherectomy, intravascular lithotripsy (IVL), scoring/cutting balloons, laser or a combined strategy may then be considered.[3,4]

Calcified coronary lesion that a balloon can cross but a standard NC balloon cannot expand adequately
Crossing a lesion and expanding it adequately are different problems.

Why may IVUS or OCT be used?

Angiography can underestimate calcium thickness and circumferential extent. IVUS and OCT provide cross-sectional views that help assess calcium depth and distribution, stent expansion and whether resistance is truly calcific.[35,11]

Imaging is not always feasible and does not guarantee better long-term outcomes by itself.[11]

Assessment of a calcified coronary lesion by angiography, IVUS and OCT
IVUS and OCT can help assess calcium morphology and stent expansion for procedural planning.

How is the procedure performed?

The procedure is done in a catheter laboratory equipped for coronary angiography and PCI:[20,21]

  1. Preparation: History, medicines, blood tests, kidney function and contrast risk are reviewed.
  2. Access: Radial or femoral artery under local anaesthesia.
  3. Angiography and wire: The artery is imaged; a fine wire is advanced beyond the stenosis.
  4. Lesion assessment: Standard balloon behaviour and, when used, IVUS/OCT findings are reviewed.
  5. Balloon use: A suitable super high-pressure balloon is positioned and inflated temporarily according to device instructions and the clinical plan.
  6. Result check: Flow, wall integrity, residual stenosis and stent expansion are reassessed; another method may follow.
  7. Removal: Balloon, wire and related catheters are removed; the access site is controlled.

Most patients remain awake. Brief chest discomfort during inflation should be reported if new or severe.[21]

Assessment, application and result-check stages of a super high-pressure coronary balloon procedure
The balloon is temporary; results are checked and further steps are individualised.

What does the scientific evidence show?

Randomised evidence

ISAR-CALC found similar OCT stent-expansion index for super high-pressure versus scoring balloons after inadequate NC preparation; it was not powered for hard clinical endpoints.[5]

Observational studies

Series and registries report feasibility and procedural success in undilatable or resistant lesions, but lack of controls and mixed device use limit causal attribution.[69,1113]

Systematic review and meta-analysis

A 2025 meta-analysis reported high pooled procedural success with substantial heterogeneity and mostly non-randomised designs; pooled rates are not personal success guarantees or proof of safety superiority.[14]

Ongoing or unpublished results

ISAR-CALC 2 completed on ClinicalTrials.gov without posted results as of 26 August 2026; VICTORY likewise lacks publishable comparative results for patient pages. Completion of a trial registry is not clinical-outcome evidence.[1618]

Distinction between procedural endpoints and long-term clinical outcomes in super high-pressure balloon evidence
Immediate lumen gain matters but does not by itself mean fewer heart attacks or deaths.

What are possible benefits and limitations?

Possible benefit / purposeLimitation / required caveat
Extra expansion tool after failed standard NC balloonThe balloon must be able to cross; uncrossable lesions need another strategy
May help lumen and stent expansion before stentingGood imaging or procedural results are not long-term clinical superiority
May be considered in selected underexpansion or ISRISR and underexpansion are not one disease; mechanism must be identified
Balloon is removed and adds no new permanent implantMost de novo calcified PCI plans still include a stent
May reduce need for other tools in some casesNot shown to make atherectomy or IVL unnecessary for everyone

What are the risks?

Possible complications in complex PCI include dissection, perforation, balloon damage, slow flow/no-reflow, abrupt closure, myocardial infarction or arrhythmia, access-site bleeding, contrast-related kidney injury or allergy, and later stent thrombosis or restenosis if a stent is used.[5,8,9,1114]

Not all events are balloon-specific. Anatomy, calcium, prior stents, other devices, clinical setting and comorbidities change total risk. Low rates in selected observational cohorts are not personal risk calculators.[9,1214]

What are the alternatives?

MethodCore approachKey difference from super high-pressure balloon
Standard NC balloonControlled pressure expansionOften the first and sufficient balloon option
Scoring balloonConcentrates force along external elementsAims for focused mechanical effect on plaque
Cutting balloonSmall blades for controlled linear modificationNot the same device as scoring; different profile and context
Rotational atherectomyBurr modifies superficial hard tissueMay create a path when balloons cannot cross
Intravascular lithotripsy (IVL)Pressure waves fracture calciumDifferent mechanism; balloon must still cross
Excimer laserLight energy in selected resistant settingsNot routine for every calcified stenosis

Methods may be combined; combined use is not routine for every patient.[3,4,19]

Treatment options for calcified coronary lesions based on balloon crossability, imaging and lesion morphology
Device choice rests on lesion structure and procedural response, not a single image or pressure value.

Preparation, discharge and recovery

Preparation depends on elective versus urgent setting, kidney function, bleeding risk, medicines, contrast history and access route. Do not stop prescribed medicines without advice.[20,21]

Same-day or next-day discharge may be possible after uncomplicated elective PCI; complex cases may need longer stays.[20]

Antiplatelet duration is not set by the balloon alone; it depends on stenting, acute coronary syndrome and bleeding–clotting risk. Stopping antiplatelets without advice can cause serious stent thrombosis.[20]

When should emergency services be called?

Call emergency services without delay for persistent or worsening chest pain, access-site bleeding that continues despite pressure, coldness/colour change/numbness in the treated limb, fainting, severe breathlessness or sudden weakness.[20]

Seek care for increasing access-site pain, swelling, redness, discharge or fever. Do not drive yourself with emergency symptoms.[20]

Frequently asked questions

No. In this coronary-balloon context, “OPL” is not a verified clinical or device term. OPN NC is a specific device/platform name. The general method name is “super high-pressure non-compliant coronary balloon”.[5,22]

No. The balloon is inflated temporarily and removed at the end of the procedure. If a stent is placed, the lasting structure in the artery is the stent.[20,21]

No. The aim is not to dissolve or remove all calcium, but to help the artery and stent expand adequately in selected resistant lesions.[35]

No. Pressure alone is not the treatment goal. Vessel diameter, balloon size, calcium distribution, stent status and the risk of vessel-wall injury are assessed together.[3,4,15]

In PCI for de novo calcified lesions the balloon is usually used before stenting. In stent underexpansion or ISR a stent may already be present. The final plan depends on the lesion and procedural result.[5,1113]

Not always. Lesions that a balloon cannot cross may need atherectomy. Deep or circumferential calcium may favour IVL. More than one method may be combined.[3,4]

Lumen gain and stent expansion are important procedural endpoints, but comparative evidence that this balloon reduces death or myocardial infarction is not available at adequate scale.[5,14]

Timing depends on elective versus urgent setting, access route, stent and adjunct devices, complications and overall health. Follow personal discharge advice for activity and return to work.[20]

Assessment and decision

A super high-pressure coronary balloon is a specialised option when a standard NC balloon cannot expand selected resistant lesions. Planning is broader than “is higher pressure needed?” and includes treatment need, device crossability, calcium morphology, stent status, IVUS/OCT findings and alternatives.[15]

Literature

References

  1. Lawton JS, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. Circulation. 2022. DOI: 10.1161/CIR.0000000000001038.

  2. Vrints C, et al. 2024 ESC Guidelines for chronic coronary syndromes. Eur Heart J. 2024. DOI: 10.1093/eurheartj/ehae177.

  3. Barbato E, et al. EAPCI consensus on heavily calcified coronary stenoses. Eur Heart J. 2023. DOI: 10.1093/eurheartj/ehad342.

  4. Riley RF, et al. SCAI Expert Consensus on Calcified Coronary Lesions. JSCAI. 2024. DOI: 10.1016/j.jscai.2023.101259.

  5. Rheude T, et al. ISAR-CALC randomised trial. EuroIntervention. 2021. DOI: 10.4244/EIJ-D-20-01000.

  6. Raja Y, et al. Catheter Cardiovasc Interv. 2010. DOI: 10.1002/ccd.22430.

  7. Díaz JF, et al. Tex Heart Inst J. 2012. PMID: 23109756.

  8. Secco GG, et al. EuroIntervention. 2016. DOI: 10.4244/EIJY15M06_04.

  9. Secco GG, et al. Cardiovasc Revasc Med. 2019. DOI: 10.1016/j.carrev.2019.02.026.

  10. Rheude T, et al. JACC Cardiovasc Interv. 2022. Publisher record linked from master.

  11. Pinilla-Echeverri N, et al. Cardiovasc Revasc Med. 2023. DOI: 10.1016/j.carrev.2023.02.020.

  12. Seiler T, et al. Cardiovasc Revasc Med. 2023. PMID: 36085285.

  13. Kumaraguruparan LD, et al. Sci Rep. 2025. DOI: 10.1038/s41598-025-20488-7.

  14. Kumar S, et al. Meta-analysis of super high-pressure balloon PCI. Catheter Cardiovasc Interv. 2025. DOI: 10.1002/ccd.31403.

  15. Kladou E, et al. Best practices review. Am J Cardiol. 2026. DOI: 10.1016/j.amjcard.2026.01.009.

  16. Scalamogna M, et al. ISAR-CALC 2 design. Cardiovasc Revasc Med. 2023. DOI: 10.1016/j.carrev.2022.12.008.

  17. ClinicalTrials.gov. ISAR-CALC 2 NCT05072730.

  18. ClinicalTrials.gov. VICTORY NCT05346068.

  19. Scalamogna M, et al. Modified balloons meta-analysis. Clin Res Cardiol. 2024. PMID: 37930402.

  20. NHS. Coronary angioplasty — Recovery. Accessed 26 August 2026.

  21. NHS. Coronary angioplasty — How it's performed. Accessed 26 August 2026.

  22. SIS Medical. OPN NC product information (device identity only).

  23. Klein LW, et al. SCAI consensus on ISR and stent thrombosis. JSCAI. 2023. DOI: 10.1016/j.jscai.2023.100971.